Note: Chemgenes's revenues are gauged from an analysis of company filings.
Chemgenes's Income Statement (based on Industry Averages)
Chemgenes P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Trademark Applications
Trademark applications show the products and services that Chemgenes is developing and marketing.
Chemgenes's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
CPSG Chemical compounds used in the pharmaceutical and biosimilar industries for the synthesis of amidites, phosphoramidites, oligonucleotides, nucleotides, nucleosides, DNA and RNA
03/02/2023
CHEMGENES Diagnostic preparations for medical and veterinary medical purposes comprising nucleic acids and enzymes; blood test kits comprising diagnostic reagents and nucleic acids for in vitro medical diagnostic use; nucleic acid sequences for medical and veterinary purposes
01/09/2009
See all trademarks and details in the Full Report.
Market Share of Chemgenes's Largest Competitors
A competitive analysis shows these companies are in the same general field as Chemgenes, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Chemgenes.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Chemgenes and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.